Wizylizumab (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Wizylizumab" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
8,738th place
165th place
719th place
1,030th place
3,174th place
1,821st place

corporate-ir.net

phx.corporate-ir.net

  • News Releases [online], phx.corporate-ir.net [dostęp 2017-11-27].

doi.org

dx.doi.org

  • Paul A. Carpenter i inni, A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease, „Blood”, 99 (8), 2002, s. 2712-279, DOI10.1182/blood.V99.8.2712, PMID11929757.
  • Daniel C. Baumgart, William J. Sandborn, Inflammatory bowel disease: clinical aspects and established and evolving therapies, „The Lancet”, 369 (9573), 2007, s. 1641-1657, DOI10.1016/S0140-6736(07)60751-X, PMID17499606.
  • Pieter C.F. Stokkers, Daniel W. Hommes, Novel biological therapies for inflammatory bowel disease, „Current Treatment Options in Gastroenterology”, 9 (3), 2006, s. 201-210, DOI10.1007/s11938-006-0039-y, PMID16901384.

medscape.com

mp.pl

nih.gov

ncbi.nlm.nih.gov

  • Paul A. Carpenter i inni, A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease, „Blood”, 99 (8), 2002, s. 2712-279, DOI10.1182/blood.V99.8.2712, PMID11929757.
  • Daniel C. Baumgart, William J. Sandborn, Inflammatory bowel disease: clinical aspects and established and evolving therapies, „The Lancet”, 369 (9573), 2007, s. 1641-1657, DOI10.1016/S0140-6736(07)60751-X, PMID17499606.
  • Pieter C.F. Stokkers, Daniel W. Hommes, Novel biological therapies for inflammatory bowel disease, „Current Treatment Options in Gastroenterology”, 9 (3), 2006, s. 201-210, DOI10.1007/s11938-006-0039-y, PMID16901384.